CEVA, Inc. — 2013 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2013. The filing also provides fourth-quarter results. Unless stated otherwise, financial amounts below are U.S. dollars.
Business context
CEVA licenses digital signal processor (DSP) cores and related intellectual property and platforms to semiconductor companies and OEMs. Revenue comes mainly from licensing and related fees and royalties on licensees’ product shipments. Licensees shipped approximately 1.01 billion CEVA-powered chipsets in 2013. The company reported one operating segment.
Financial performance and liquidity
| Metric | 2013 | 2012 |
|---|---|---|
| Total revenue | $48.9 million | $53.7 million |
| Licensing and related revenue | $22.4 million | $21.7 million |
| Royalties | $26.5 million | $32.0 million |
| Gross profit / gross margin | $43.7 million / 89.4% | $49.7 million / 92.6% |
| Operating income / operating margin | $4.8 million / 9.7% | $12.4 million / 23.0% |
| Net income | $6.7 million | $13.7 million |
| Diluted earnings per share | $0.30 | $0.59 |
| Cash from operating activities | $13.7 million | $18.6 million |
| Working capital at year-end | $131.4 million | $131.5 million |
Fourth-quarter 2013 revenue was $14.0 million, operating income $2.8 million and net income $3.1 million; fourth-quarter 2012 amounts were $13.0 million, $2.4 million and $2.8 million, respectively.
At year-end, cash and cash equivalents were $24.1 million, short-term bank deposits $41.9 million, marketable securities $68.5 million and long-term deposits $17.1 million, totaling approximately $151.6 million. CEVA reported no long-term debt or capital lease obligations. Long-term liabilities were $7.3 million, primarily accrued severance obligations. Total assets were $212.3 million and stockholders’ equity $190.9 million.
CEVA repurchased 1,257,004 shares during 2013 for approximately $19.8 million. The company stated its available cash, deposits, securities and operating cash flow were expected to fund operations for at least 12 months.
Material changes versus 2012
- Revenue fell 8.9%, chiefly because royalties declined 17.0%; licensing and related revenue increased 3.0%.
- Management attributed weaker royalties mainly to lower feature-phone shipments, 2G chip price erosion and contraction in legacy consumer electronics. Total reported chipset shipments declined to 1.010 billion from 1.082 billion.
- Cost of revenue rose 30.6%, and operating expenses rose 4.3%. Operating income consequently fell to $4.8 million from $12.4 million; net income fell to $6.7 million from $13.7 million.
- Licensing and related revenue increased with activity in new market segments, particularly multimedia. CEVA signed 30 licensing agreements, 17 with first-time customers; 11 agreements were signed in the fourth quarter.
- Revenue concentration increased: the largest customer represented 28% of revenue and the second-largest 11%, versus 24% and 13% in 2012. Five largest royalty-paying customers accounted for 87.3% of royalty revenue, up from 81.6%.
Outlook, risks and unusual items
- Management expected 2014 annual operating expenses to be higher than in 2013, mainly because of increased R&D headcount and related costs. No revenue or earnings guidance was provided in the supplied filing text.
- Management cited low-cost smartphones in developing markets, broader future 4G/LTE adoption, base-station applications, audio and voice processing, and computational photography and vision as potential growth drivers. These are expectations, not assured outcomes.
- Key risks include dependence on a small group of royalty customers; handset and mobile-broadband exposure (77% of revenue in 2013); competition, royalty-rate and product-price erosion; customer shipment and design-cycle variability; and reliance on customer products achieving market acceptance.
- International operations expose CEVA to currency, geopolitical and regulatory risks, including risks related to Israel. Foreign-currency hedging may not fully offset exchange-rate movements. Israeli investment-program tax benefits were scheduled to begin expiring in 2014.
- Potential obligations include $8.6 million of contingent royalties to Israel’s Office of the Chief Scientist, payable based on sales of certain grant-funded products, and $3.6 million of uncertain tax positions whose payment timing could not be reliably estimated. The company reported no litigation expected to have a material adverse effect.
- There were no other-than-temporary impairment charges on marketable securities in 2011–2013. The independent auditor issued an unqualified opinion on the financial statements and internal controls; management also concluded controls were effective at year-end.
Important facts for investors to verify
- Whether royalties stabilize or continue to decline, particularly as feature-phone volumes and chip average selling prices change.
- Whether the increase in new-market licensing activity converts into recurring royalties and diversified revenue.
- Customer concentration and shipment trends, including the effect of the largest customers on future results.
- Whether higher planned R&D spending supports growth without further materially reducing operating margins and cash generation.
- Liquidity and investment risks, including the composition, maturities and credit exposure of deposits and marketable securities, and the status of tax and OCS obligations.